Oncology (Williston Park, N.Y.)

publication venue for

Sharing Serious News With Cancer Patients: Strategies That Can Help.. 32. 2018
Diagnosing and Managing Delirium in Cancer Patients.. 31. 2017
Point/Counterpoint: Primary Debulking Surgery vs Neoadjuvant Chemotherapy for Newly Diagnosed Advanced Ovarian Cancer.. 31. 2017
Low-Grade Serous Carcinoma of the Ovary.. 30. 2016
COUNTERPOINT: Is Immediate Radical Cystectomy Justified When Non-Muscle-Invasive Bladder Cancer First Presents as High-Grade T1 Urothelial Carcinoma on Re-Resection?. 30. 2016
Diabetes Management in Cancer Patients.. 30. 2016
Chemotherapy-Induced Peripheral Neuropathy.. 30. 2016
When to Combine Endocrine Therapy With a New Agent for Hormone Receptor-Positive Metastatic Breast Cancer in Postmenopausal Women.. 30. 2016
Chemotherapy-Induced Cardiomyopathy: Clinical Scenarios and Challenges.. 29. 2015
Is classical stereotactic radiotherapy the optimal partner for immunotherapy?. 29. 2015
Best practices in the management of newly diagnosed multiple myeloma patients who will not undergo transplant.. 24. 2010
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities.. 24. 2010
Improving adherence to endocrine therapies: the role of advanced practice nurses.. 20. 2006
Phase II trial of weekly irinotecan/cisplatin in advanced esophageal cancer.. 18. 2004
Irinotecan in esophageal cancer.. 17. 2003
Stress and burnout in oncology.. 14. 2000
Postoperative radiation therapy for rectal cancer combined with UFT/leucovorin.. 14. 2000
Management of renal cell carcinoma.. 14. 2000
Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect.. 13. 1999
Implementation of practice guidelines.. 11. 1997
NCCN adult brain tumor practice guidelines.. 11. 1997
Update of the NCCN guidelines for treatment of breast cancer.. 11. 1997
Cisplatin/paclitaxel vs cisplatin/teniposide for advanced non-small-cell lung cancer. The EORTC Lung Cancer Cooperative Group. The European Organization for Research and Treatment of Cancer.. 11. 1997
Comentary (Steinherz): Toxicity of CNS Prophylaxis for Childhood Leukemia.. 11. 1997
Development and implementation of clinical management guidelines.. 10. 1996
Outcomes research studies.. 10. 1996
Current management of lobular carcinoma in situ of the breast.. 8. 1994
Cervical lymph node metastases--diagnostic, therapeutic, and prognostic implications.. 4. 1990
Quality of life assessment of Hodgkin's disease survivors: a model for cooperative clinical trials.. 4. 1990
More on facing the reality of our aging population with breast cancer.. 26. 2012
Patients with H pylori-independent MALT lymphoma are curable with radiotherapy.. 25. 2011
Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunities.. 25. 2011
Anthracyclines are a critical component of adjuvant chemotherapy regimens for high-risk early breast cancer.. 25. 2011
Improving the therapeutic benefits of ipilimumab.. 24. 2010
Changing management strategies for hepatic colorectal metastasis.. 23. 2009
Can risk-adapted treatment recommendations replace the 'one size fits all' approach for early-stage thyroid cancer patients?. 23. 2009
Management of early ovarian cancer.. 18. 2004
Treatment of metastatic pancreatic adenocarcinoma: new options and promising strategies. 2014
Brain metastasis in breast cancer: last barrier to the cure? 2012
Splenic lymphomas: is there still a role for splenectomy? 2012
Comments regarding lung metastasis surgery for sarcoma. 2011
Seeing red: anthracyclines for breast cancer. 2011
Cancer stem cells, EMT, and seeding: a rose is a rose is a rose? 2011
Pancreatic adenocarcinoma: new approaches to a challenging malignancy. 2010
The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization. 2010
Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. 2008
More on the treatment of anal margin carcinomas. 1997
The Uncertainties of Rituximab and Related Therapies, 20 Years After Approval.. 31. 2017
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 1: Lumpectomy, Mastectomy, and Contralateral Prophylactic Mastectomy. 2017
Decision Making in the Surgical Management of Invasive Breast Cancer-Part 2: Expanded Applications for Breast-Conserving Surgery. 2017
Next Generation of Targeted Molecules for Non-Hodgkin Lymphomas: Small-Molecule Inhibitors of Intracellular Targets and Signaling Pathways. 2016
Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers. 2016
CTLA-4 antibodies: new directions, new combinations. 2014
Expanding androgen- and androgen receptor signaling-directed therapies for castration-resistant prostate cancer. 2014
Management of the clinically node-negative axilla: what have we learned from the clinical trials? 2014
Acr appropriateness Criteria management of vaginal cancer. 2013
Provocative pearls in diagnosing and treating acute promyelocytic leukemia. 2012
Treatment of acute promyelocytic leukemia without cytotoxic chemotherapy. 2011
Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target? 2010
HER2-positive breast cancer: beyond trastuzumab. 2010
Inhibition of poly(ADP)-ribose polymerase as a therapeutic strategy for breast cancer. 2010
Bevacizumab in the treatment of metastatic breast cancer. 2009
Stereotactic body radiotherapy in the management of painful bone metastases. 2008
MRI and breast cancer: role in detection, diagnosis, and staging. 2007
Reproductive issues in the gynecologic cancer patient. 2007
Emerging role of immunotherapy in the management of prostate cancer. 2007
Management of liver metastases from colorectal cancer. 2006
Systemic treatment of breast cancer. Two decades of progress. 2006
Radiation therapy in the management of brain metastases from renal cell carcinoma. 2006
EGFR inhibitors in lung cancer. 2005
Metastatic colorectal cancer: is there one standard approach? 2005
Emerging targeted therapies for breast cancer. 2005
Infectious complications of lung cancer. 2005
Gemcitabine and docetaxel in metastatic breast cancer. 2004
Delirium in palliative care. 2004
Depression in cancer patients. 2004
Surgical cytoreduction in ovarian cancer. 2004
Management of early ovarian cancer. 2004
Introduction. Single-agent or combination chemotherapy in metastatic breast cancer. 2003
Risk models for chemotherapy-induced neutropenia in non-Hodgkin's lymphoma. 2003
Risk models for neutropenia in patients with breast cancer. 2003
Cervical cancer: issues of sexuality and fertility. 2003
Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications. 2003
HER2 testing and correlation with efficacy of trastuzumab therapy. 2002
Prostate-specific antigen as a marker of disease activity in prostate cancer. 2002
Prostate-specific antigen as a marker of disease activity in prostate cancer. 2002
Current perspectives on pain in AIDS. 2002
Current perspectives on pain in AIDS. 2002
Irinotecan, cisplatin, and radiation in esophageal cancer. 2002
Potential role of selective COX-2 inhibitors in cancer management. 2002
Oral chemotherapy for colorectal cancer: some economic considerations. 2001
Perspectives on fluorinated pyrimidine use in gastrointestinal and breast oncology. 2001
Laparoscopy in gynecologic malignancies. 1999
Update on the management of advanced breast cancer. 1999
Progress toward guidelines for the management of fatigue. 1998
Role of laparoscopic techniques in colorectal cancer surgery. 1995
Percutaneous endoscopic stomas for enteral feeding and drainage. 1995
Adjuvant postoperative therapy of gastrointestinal malignancies. 1994
A review of idarubicin in acute leukemia. 1993
Neoadjuvant therapy for gastrointestinal cancers. 1993
Autoimmune disease and silicone breast implants. 1993
Chemotherapy as part of the initial treatment for nasopharyngeal cancer. 1991
Radiotherapy vs intrathecal chemotherapy for CNS prophylaxis in childhood ALL. 1989
Current status of chemotherapy for urothelial tract tumors. 1987
Current status of antitumor therapy with monoclonal antibodies. 1987
Suicide in cancer patients. 1987
Non-Small-Cell Lung Cancer After Mantle Radiation: A Case Report and Brief Review. 2019
DLBCL Cell of Origin: What Role Should It Play in Care Today? 2018
CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer? 2018
Active Surveillance for Prostate Cancer: How to Do It Right. 2017
The Management of Advanced Germ Cell Tumors in 2016: The Memorial Sloan Kettering Approach. 2016
Is Personalized Medicine Here? 2016
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions. 2015
Cancer stem cells: implications for cancer therapy. 2014
Postmenopausal hormone receptor-positive advanced breast cancer. 2013
Genetic testing in gastrointestinal cancers: a case-based approach. 2012
Inflammatory breast cancer: what progress have we made? 2011
Genome-wide association studies of cancer: principles and potential utility. 2010
Management of relapsed mantle cell lymphoma: still a treatment challenge. 2009
Anthracycline cardiotoxicity after breast cancer treatment. 2009
What is the optimal treatment of localized pancreatic adenocarcinoma? 2008
Chemotherapeutic Strategies for advanced breast cancer. 2007
What progress have we made in managing inflammatory breast cancer? 2007
Novel targets and therapies for metastatic renal cell carcinoma. 2006
Osteonecrosis of the jaw in cancer patients receiving IV bisphosphonates. 2006
Erlotinib: preclinical investigations. 2003
Pancreatic cancer: epidemiology, genetics, and approaches to screening. 2002
Irinotecan and cisplatin in upper gastrointestinal malignancies. 1998
BCG immunotherapy for transitional-cell carcinoma in situ of the bladder. 1995
Current combined treatment of high-grade osteosarcomas. 1995
Current management of primary central nervous system lymphoma. 1995
Primary CNS lymphoma: managing patients with spontaneous and AIDS-related disease. 1987
NCCN practice guidelines for head and neck cancer. National Comprehensive Cancer Network. 1998
Colorectal cancer surgical practice guidelines. Colorectal Cancer Practice Guideline Committee. 1997

VIVO Weill Cornell Medical College

Oncology (Williston Park, N.Y.) Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)